
Global Respiratory Care Device Market Report and Forecast 2024-2032
Description
Global Respiratory Care Device Market Report and Forecast 2024-2032
Global Respiratory Care Device Market Report and Forecast 2024-2032
The global respiratory care device market reached a value of around USD 21.67 billion in 2023, fuelled by the rise in severe respiratory diseases across the globe. The market is expected to grow at a CAGR of 8.60% during the forecast period of 2024-2032 and expected to attain a market value of around USD 45.3 billion by 2032.
Global Respiratory Care Device Market Analysis
The global respiratory care device market is a rapidly evolving sector, driven by increasing respiratory ailments, technological advancements, and a growing elderly population.
Market Drivers
- Rising Prevalence of Respiratory Diseases: The primary driver for the respiratory care device market is the increasing incidence of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. Urbanization and rising pollution levels further exacerbate these conditions, boosting demand for respiratory care devices.
- Aging Population: Older adults are more susceptible to respiratory diseases due to weakened immune systems and reduced lung capacity. With the global population aging, the demand for respiratory care is expected to increase significantly.
- Technological Advancements: Innovations in respiratory care devices, such as smart inhalers and portable ventilators, are enhancing patient outcomes and compliance. These advancements are making treatments more efficient and user-friendly, thereby increasing their adoption.
- COVID-19 Impact: The COVID-19 pandemic has brought unprecedented attention to respiratory health, leading to a surge in demand for respiratory care devices, especially ventilators and airway management devices, to treat virus-infected patients.
- Healthcare Expenditure and Insurance Coverage: Increasing healthcare spending and better insurance coverage for respiratory therapies and devices are making treatments more accessible, thus driving market growth.
- High Cost of Devices: Advanced respiratory care devices can be expensive, making them less accessible in low- and middle-income countries. This cost factor is a significant barrier to the adoption of newer technologies.
- Regulatory Hurdles: Stringent regulatory requirements for the approval of medical devices can delay product launches and add to development costs. This regulatory environment can inhibit the growth of the respiratory care devices market.
- Limited Awareness in Emerging Economies: In many developing regions, there is limited awareness about the latest respiratory care devices and their benefits, which hinders market penetration.
- Reimbursement Issues: Inconsistent reimbursement policies for respiratory therapies and devices can affect market growth, as patients might forego advanced treatments due to out-of-pocket costs.
- Emerging Markets: Developing countries present significant opportunities for the respiratory care device market due to rising healthcare infrastructure, increasing disposable incomes, and growing awareness about respiratory health.
- Home Care Respiratory Devices: There is a growing trend towards home healthcare, driven by the patient preference for receiving care in the comfort of their own homes. This shift is expected to increase the demand for portable and easy-to-use respiratory devices.
- Integration of Artificial Intelligence: AI and machine learning are being integrated into respiratory devices to provide insights into patient health trends and improve device functionality. This technological integration represents a key area of growth.
- Sustainable and Advanced Materials: Development of devices using sustainable materials that reduce environmental impact and enhance patient compatibility can open new avenues for innovation and market expansion.
- Collaborations and Mergers: Strategic alliances and mergers between key players can lead to better R&D capabilities, enhanced market reach, and expanded product portfolios, driving further growth in the sector.
Global Respiratory Care Device Market Trends
The global respiratory care device market is experiencing significant growth due to increasing health awareness and advancements in medical technology. As populations age and environmental factors impact respiratory health, the demand for innovative and effective respiratory solutions continues to surge. Here are some key market trends:
- Shift Towards Portable Devices: There's a growing preference for portable respiratory care devices, driven by the increasing demand for home healthcare services. Portable devices like handheld inhalers, compact nebulizers, and lightweight oxygen concentrators are becoming more popular as they offer patients the freedom to maintain their mobility and lifestyle.
- Smart Technology Integration: Respiratory devices are increasingly being integrated with smart technologies that enable remote monitoring and data analysis. Features such as Wi-Fi connectivity and compatibility with mobile apps allow healthcare providers to monitor patients' conditions in real-time, enhancing treatment efficacy and patient engagement.
- Focus on Customization and Patient Comfort: Manufacturers are focusing on developing devices that are not only effective but also comfortable for long-term use. This includes features like improved mask fits for CPAP machines and quieter operation, which enhance user compliance and comfort.
- Expansion of Product Range and Applications: Companies are expanding their product portfolios to include a wider range of treatment options, catering to various respiratory conditions from mild asthma to severe COPD. This diversification helps companies tap into broader markets and meet specific patient needs.
- Regulatory and Standardization Advances: There is an increasing emphasis on meeting stringent regulatory standards and achieving certifications that ensure the safety and effectiveness of respiratory devices. Compliance with these standards is crucial for market entry and expansion, particularly in regulated markets like the US and Europe.
Global Respiratory Care Device Market Segmentation
Market Breakup by Product
- Therapeutic Respiratory Care Devices
- Positive Airway Pressure (PAP) Devices
- Oxygen Concentrator
- Ventilators
- Inhalers
- Nebulizers
- Humidifiers
- Reusable Resuscitators
- Nitric Oxide Delivery Units
- Oxygen Hoods
- Respiratory Care Monitoring Devices
- Pulse Oximeter
- Capnography
- Gas Analyzers
- Diagnostic Respiratory Care Devices
- Spirometer
- Polysomnography Devices
- Peak Flow Meter
- Others
Market Breakup by Disease Indications
- COPD
- Asthma
- Sleep Apnea
- Infectious Disease
- Others
Market Breakup by End User
- Hospitals and Clinics
- Home Care
- Ambulatory Care
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America leads the market, driven by advanced healthcare systems, high healthcare expenditure, and a strong presence of leading respiratory device manufacturers. The region's focus on innovative technologies and the high prevalence of respiratory diseases further stimulate market growth.
Europe follows closely, with a robust healthcare framework and substantial investments in healthcare research and development. The region's aging population and increasing air pollution contribute significantly to the demand for respiratory care devices.
Asia Pacific is the fastest-growing region, fueled by rising healthcare awareness, increasing disposable incomes, and healthcare infrastructure improvements in emerging economies like China and India. The increasing burden of respiratory diseases in this densely populated region also drives demand.
Latin America and the Middle East and Africa are expected to witness substantial growth due to the expanding healthcare sectors and increasing government initiatives to improve healthcare accessibility. These regions are increasingly adopting respiratory care devices to address a growing prevalence of respiratory conditions and improving the overall healthcare landscape.
Each region contributes to the global market's expansion, with North America and Asia Pacific leading in technology adoption and market size, respectively, while emerging markets in Latin America and the Middle East and Africa present significant growth opportunities due to evolving healthcare needs and economic development.
Global Respiratory Care Device Market Competitive Landscape
The competitive landscape of the global respiratory care device market is dynamic, featuring a mix of established companies and innovative newcomers that actively engage in various strategic activities to strengthen their market positions. Koninklijke Philips N.V. and ResMed Inc. are at the forefront, regularly introducing advanced products and participating in mergers and acquisitions to expand their global footprint. Masimo Corporation and General Electric Company emphasize research and development to innovate new solutions that enhance patient outcomes. Teleflex Incorporated, Fisher & Paykel Healthcare Corporation Limited, and Hamilton Medical AG focus on expanding their product lines and entering new markets through strategic partnerships and acquisitions. ICU Medical Inc. and Getinge AB concentrate on broadening their reach with new and upgraded products, backed by strong R&D investments. Aerin Medical Inc. and VitalAire Canada Inc. are smaller players but are progressively making their mark through niche product innovations and regional expansion efforts. Collectively, these activities help drive the market's growth, addressing an increasing demand for respiratory care solutions worldwide.
Key Questions Answered in the Report
- What is the current and future performance of the respiratory care device market?
- What are the main challenges facing the respiratory care device market?
- What are the key drivers of the respiratory care device market?
- What emerging trends are shaping the future of the respiratory care device market?
- How are aging populations influencing the demand for therapeutic respiratory devices?
- How do smoking and pollution levels impact the demand for COPD-targeting devices?
- What factors are driving the demand for respiratory care devices in Europe?
- Why are portable respiratory care devices becoming more popular in home healthcare?
- How are Aerin Medical Inc. and VitalAire Canada Inc. impacting the respiratory care market?
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global respiratory care device market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the respiratory care device market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global respiratory care device industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
Table of Contents
200 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Respiratory Care Device Market Overview
- 3.1 Global Respiratory Care Device Market Historical Value (2017-2023)
- 3.2 Global Respiratory Care Device Market Forecast Value (2024-2032)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Respiratory Care Device Market Landscape*
- 5.1 Global Respiratory Care Device: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Respiratory Care Device: Product Landscape
- 5.2.1 Analysis by Type
- 5.2.2 Analysis by Disease Indication
- 6 Global Respiratory Care Device Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Respiratory Care Device Market, Epidemiology Snapshot
- 7.1 Overview of Global Respiratory Disease Incidence Number (2017-2032)
- 7.2 Incidence Number, By Indication (2017-2032)
- 7.2.1.1 COPD
- 7.2.1.2 Asthma
- 7.2.1.3 Sleep Apnea
- 7.2.1.4 Infectious Disease
- 7.2.1.5 Others
- 8 Global Respiratory Care Device Market Segmentation (2017-2032)
- 8.1 Global Respiratory Care Device Market (2017-2032) by Product
- 8.1.1 Market Overview
- 8.1.2 Therapeutic Respiratory Care Devices
- 8.1.2.1 Positive Airway Pressure (PAP) Devices
- 8.1.2.2 Oxygen Concentrator
- 8.1.2.3 Ventilators
- 8.1.2.4 Inhalers
- 8.1.2.5 Nebulizers
- 8.1.2.6 Humidifiers
- 8.1.2.7 Reusable Resuscitators
- 8.1.2.8 Nitric Oxide Delivery Units
- 8.1.2.9 Oxygen Hoods
- 8.1.3 Respiratory Care Monitoring Devices
- 8.1.3.1 Pulse Oximeter
- 8.1.3.2 Capnography
- 8.1.3.3 Gas Analyzers
- 8.1.4 Diagnostic Respiratory Care Devices
- 8.1.4.1 Spirometer
- 8.1.4.2 Polysomnography Devices
- 8.1.4.3 Peak Flow Meter
- 8.1.4.4 Others
- 8.2 Global Respiratory Care Device Market (2017-2032) by Disease Indications
- 8.2.1 Market Overview
- 8.2.2 COPD
- 8.2.3 Asthma
- 8.2.4 Sleep Apnea
- 8.2.5 Infectious Disease
- 8.2.6 Others
- 8.3 Global Respiratory Care Device Market (2017-2032) by End User
- 8.3.1 Market Overview
- 8.3.2 Hospitals
- 8.3.3 Home Care
- 8.3.4 Ambulatory Care
- 8.3.5 Others
- 8.4 Global Respiratory Care Device Market (2017-2032) by Region
- 8.4.1 Market Overview
- 8.4.2 North America
- 8.4.3 Europe
- 8.4.4 Asia Pacific
- 8.4.5 Latin America
- 8.4.6 Middle East and Africa
- 9 North America Respiratory Care Device Market (2017-2032)
- 9.1 North America Respiratory Care Device Market (2017-2032) by Product
- 9.1.1 Market Overview
- 9.1.2 Therapeutic Respiratory Care Devices
- 9.1.2.1 Positive Airway Pressure (PAP) Devices
- 9.1.2.2 Oxygen Concentrator
- 9.1.2.3 Ventilators
- 9.1.2.4 Inhalers
- 9.1.2.5 Nebulizers
- 9.1.2.6 Humidifiers
- 9.1.2.7 Reusable Resuscitators
- 9.1.2.8 Nitric Oxide Delivery Units
- 9.1.2.9 Oxygen Hoods
- 9.1.3 Respiratory Care Monitoring Devices
- 9.1.3.1 Pulse Oximeter
- 9.1.3.2 Capnography
- 9.1.3.3 Gas Analyzers
- 9.1.4 Diagnostic Respiratory Care Devices
- 9.1.4.1 Spirometer
- 9.1.4.2 Polysomnography Devices
- 9.1.4.3 Peak Flow Meter
- 9.1.4.4 Others
- 9.2 North America Respiratory Care Device Market (2017-2032) by Disease Indications
- 9.2.1 Market Overview
- 9.2.2 COPD
- 9.2.3 Asthma
- 9.2.4 Sleep Apnea
- 9.2.5 Infectious Disease
- 9.2.6 Others
- 9.3 North America Respiratory Care Device Market (2017-2032) by End User
- 9.3.1 Market Overview
- 9.3.2 Hospitals
- 9.3.3 Home Care
- 9.3.4 Ambulatory Care
- 9.3.5 Others
- 9.4 North America Respiratory Care Device Market (2017-2032) by Country
- 9.4.1 United States of America
- 9.4.2 Canada
- 10 Europe Respiratory Care Device Market (2017-2032)
- 10.1 Europe Respiratory Care Device Market (2017-2032) by Product
- 10.1.1 Market Overview
- 10.1.2 Therapeutic Respiratory Care Devices
- 10.1.2.1 Positive Airway Pressure (PAP) Devices
- 10.1.2.2 Oxygen Concentrator
- 10.1.2.3 Ventilators
- 10.1.2.4 Inhalers
- 10.1.2.5 Nebulizers
- 10.1.2.6 Humidifiers
- 10.1.2.7 Reusable Resuscitators
- 10.1.2.8 Nitric Oxide Delivery Units
- 10.1.2.9 Oxygen Hoods
- 10.1.3 Respiratory Care Monitoring Devices
- 10.1.3.1 Pulse Oximeter
- 10.1.3.2 Capnography
- 10.1.3.3 Gas Analyzers
- 10.1.4 Diagnostic Respiratory Care Devices
- 10.1.4.1 Spirometer
- 10.1.4.2 Polysomnography Devices
- 10.1.4.3 Peak Flow Meter
- 10.1.4.4 Others
- 10.2 Europe Respiratory Care Device Market (2017-2032) by Disease Indications
- 10.2.1 Market Overview
- 10.2.2 COPD
- 10.2.3 Asthma
- 10.2.4 Sleep Apnea
- 10.2.5 Infectious Disease
- 10.2.6 Others
- 10.3 Europe Respiratory Care Device Market (2017-2032) by End User
- 10.3.1 Market Overview
- 10.3.2 Hospitals
- 10.3.3 Home Care
- 10.3.4 Ambulatory Care
- 10.3.5 Others
- 10.4 Europe Respiratory Care Device Market (2017-2032) by Country
- 10.4.1 United Kingdom
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 Italy
- 10.4.5 Others
- 11 Asia Pacific Respiratory Care Device Market (2017-2032)
- 11.1 Asia Pacific Respiratory Care Device Market (2017-2032) by Product
- 11.1.1 Market Overview
- 11.1.2 Therapeutic Respiratory Care Devices
- 11.1.2.1 Positive Airway Pressure (PAP) Devices
- 11.1.2.2 Oxygen Concentrator
- 11.1.2.3 Ventilators
- 11.1.2.4 Inhalers
- 11.1.2.5 Nebulizers
- 11.1.2.6 Humidifiers
- 11.1.2.7 Reusable Resuscitators
- 11.1.2.8 Nitric Oxide Delivery Units
- 11.1.2.9 Oxygen Hoods
- 11.1.3 Respiratory Care Monitoring Devices
- 11.1.3.1 Pulse Oximeter
- 11.1.3.2 Capnography
- 11.1.3.3 Gas Analyzers
- 11.1.4 Diagnostic Respiratory Care Devices
- 11.1.4.1 Spirometer
- 11.1.4.2 Polysomnography Devices
- 11.1.4.3 Peak Flow Meter
- 11.1.4.4 Others
- 11.2 Asia Pacific Respiratory Care Device Market (2017-2032) by Disease Indications
- 11.2.1 Market Overview
- 11.2.2 COPD
- 11.2.3 Asthma
- 11.2.4 Sleep Apnea
- 11.2.5 Infectious Disease
- 11.2.6 Others
- 11.3 Asia Pacific Respiratory Care Device Market (2017-2032) by End User
- 11.3.1 Market Overview
- 11.3.2 Hospitals
- 11.3.3 Home Care
- 11.3.4 Ambulatory Care
- 11.3.5 Others
- 11.4 Asia Pacific Respiratory Care Device Market (2017-2032) by Country
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 ASEAN
- 11.4.5 Australia
- 11.4.6 Others
- 12 Latin America Respiratory Care Device Market (2017-2032)
- 12.1 Latin America Respiratory Care Device Market (2017-2032) by Product
- 12.1.1 Market Overview
- 12.1.2 Disposable Sensors
- 12.1.3 Reusable Probes
- 12.2 Latin America Respiratory Care Device Market (2017-2032) by Product Type
- 12.2.1 Market Overview
- 12.2.2 Therapeutic Respiratory Care Devices
- 12.2.2.1 Positive Airway Pressure (PAP) Devices
- 12.2.2.2 Oxygen Concentrator
- 12.2.2.3 Ventilators
- 12.2.2.4 Inhalers
- 12.2.2.5 Nebulizers
- 12.2.2.6 Humidifiers
- 12.2.2.7 Reusable Resuscitators
- 12.2.2.8 Nitric Oxide Delivery Units
- 12.2.2.9 Oxygen Hoods
- 12.2.3 Respiratory Care Monitoring Devices
- 12.2.3.1 Pulse Oximeter
- 12.2.3.2 Capnography
- 12.2.3.3 Gas Analyzers
- 12.2.4 Diagnostic Respiratory Care Devices
- 12.2.4.1 Spirometer
- 12.2.4.2 Polysomnography Devices
- 12.2.4.3 Peak Flow Meter
- 12.2.4.4 Others
- 12.3 Latin America Respiratory Care Device Market (2017-2032) by Disease Indications
- 12.3.1 Market Overview
- 12.3.2 COPD
- 12.3.3 Asthma
- 12.3.4 Sleep Apnea
- 12.3.5 Infectious Disease
- 12.3.6 Others
- 12.4 Latin America Respiratory Care Device Market (2017-2032) by End User
- 12.4.1 Market Overview
- 12.4.2 Hospitals
- 12.4.3 Home Care
- 12.4.4 Ambulatory Care
- 12.4.5 Others
- 12.5 Latin America Respiratory Care Device Market (2017-2032) by Country
- 12.5.1 Brazil
- 12.5.2 Argentina
- 12.5.3 Mexico
- 12.5.4 Others
- 13 Middle East and Africa Respiratory Care Device Market (2017-2032)
- 13.1 Middle East and Africa Respiratory Care Device Market (2017-2032) by Product
- 13.1.1 Market Overview
- 13.1.2 Therapeutic Respiratory Care Devices
- 13.1.2.1 Positive Airway Pressure (PAP) Devices
- 13.1.2.2 Oxygen Concentrator
- 13.1.2.3 Ventilators
- 13.1.2.4 Inhalers
- 13.1.2.5 Nebulizers
- 13.1.2.6 Humidifiers
- 13.1.2.7 Reusable Resuscitators
- 13.1.2.8 Nitric Oxide Delivery Units
- 13.1.2.9 Oxygen Hoods
- 13.1.3 Respiratory Care Monitoring Devices
- 13.1.3.1 Pulse Oximeter
- 13.1.3.2 Capnography
- 13.1.3.3 Gas Analyzers
- 13.1.4 Diagnostic Respiratory Care Devices
- 13.1.4.1 Spirometer
- 13.1.4.2 Polysomnography Devices
- 13.1.4.3 Peak Flow Meter
- 13.1.4.4 Others
- 13.2 Middle East Africa Respiratory Care Device Market (2017-2032) by Disease Indications
- 13.2.1 Market Overview
- 13.2.2 COPD
- 13.2.3 Asthma
- 13.2.4 Sleep Apnea
- 13.2.5 Infectious Disease
- 13.2.6 Others
- 13.3 Middle East and Africa Respiratory Care Device Market (2017-2032) by End User
- 13.3.1 Market Overview
- 13.3.2 Hospitals
- 13.3.3 Home Care
- 13.3.4 Ambulatory Care
- 13.3.5 Others
- 13.4 Middle East and Africa Respiratory Care Device Market (2017-2032) by Country
- 13.4.1 Saudi Arabia
- 13.4.2 United Arab Emirates
- 13.4.3 Nigeria
- 13.4.4 South Africa
- 13.4.5 Others
- 14 Regulatory Framework
- 14.1 Regulatory Overview
- 14.2 US FDA
- 14.3 EU EMA
- 14.4 INDIA CDSCO
- 14.5 JAPAN PMDA
- 14.6 Others
- 15 Patent Analysis
- 15.1 Analysis by Type of Patent
- 15.2 Analysis by Publication Year
- 15.3 Analysis by Issuing Authority
- 15.4 Analysis by Patent Age
- 15.5 Analysis by CPC Analysis
- 15.6 Analysis by Patent Valuation
- 15.7 Analysis by Key Players
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Type of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Strategic Initiatives
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership
- 17.3 Analysis by Leading Players
- 17.4 Analysis by Geography
- 18 Supplier Landscape
- 18.1 Market Share Analysis, By Region (Top 5 Companies)
- 18.1.1 Market Share Analysis: Global
- 18.1.2 Market Share Analysis: North America
- 18.1.3 Market Share Analysis: Europe
- 18.1.4 Market Share Analysis: Asia-Pacific
- 18.1.5 Market Share Analysis: Others
- 18.2 Koninklijke Philips N.V
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Mergers and Acquisitions
- 18.2.5 Certifications
- 18.3 Masimo Corporation
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Mergers and Acquisitions
- 18.3.5 Certifications
- 18.4 Teleflex Incorporated
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Mergers and Acquisitions
- 18.4.5 Certifications
- 18.5 Fisher & Paykel Healthcare Corporation Limited
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Mergers and Acquisitions
- 18.5.5 Certifications
- 18.6 Hamilton Medical AG
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Mergers and Acquisitions
- 18.6.5 Certifications
- 18.7 ICU Medical Inc.
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Mergers and Acquisitions
- 18.7.5 Certifications
- 18.8 General Electric Company
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Mergers and Acquisitions
- 18.8.5 Certifications
- 18.9 ResMed Inc.
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Mergers and Acquisitions
- 18.9.5 Certifications
- 18.10 Getinge AB
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Mergers and Acquisitions
- 18.10.5 Certifications
- 18.11 Aerin Medical Inc.
- 18.11.1 Financial Analysis
- 18.11.2 Product Portfolio
- 18.11.3 Demographic Reach and Achievements
- 18.11.4 Mergers and Acquisitions
- 18.11.5 Certifications
- 18.12 VitalAire Canada Inc.
- 18.12.1 Financial Analysis
- 18.12.2 Product Portfolio
- 18.12.3 Demographic
- 18.12.4 Mergers and Acquisitions
- 18.12.5 Certifications
- 19 Global Respiratory Care Device Market – Distribution Model (Additional Insight)
- 19.1 Overview
- 19.2 Potential Distributors
- 19.3 Key Parameters for Distribution Partner Assessment
- 20 Key Opinion Leaders (KOL) Insights (Additional Insight)
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- **The supplier list is not exhaustive, moreover we can provide analysis of companies as per custom request.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.